Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,407
Closed -$574K 1809
2026
Q1
$574K Sell
6,407
-14,135
-69% -$1.36M ﹤0.01% 1156
2025
Q4
$1.91M Buy
+20,542
New +$2.24M 0.02% 787
2025
Q3
Sell
-16,557
Closed -$2.18M 1769
2025
Q2
$2.18M Buy
+16,557
New +$1.87M 0.02% 720
2024
Q4
Sell
-39,715
Closed -$4.24M 1762
2024
Q3
$4.24M Buy
39,715
+2,892
+8% +$293K 0.03% 479
2024
Q2
$3.64M Buy
+36,823
New +$3.71M 0.02% 544
2024
Q1
Sell
-18,008
Closed -$1.36M 1718
2023
Q4
$1.36M Buy
18,008
+12,773
+244% +$831K 0.01% 699
2023
Q3
$317K Sell
5,235
-2,677
-34% -$184K ﹤0.01% 1401
2023
Q2
$570K Sell
7,912
-1,831
-19% -$116K ﹤0.01% 1304
2023
Q1
$540K Buy
9,743
+2,997
+44% +$165K ﹤0.01% 1318
2022
Q4
$342K Sell
6,746
-15,920
-70% -$787K 0.01% 1306
2022
Q3
$954K Buy
22,666
+9,466
+72% +$471K 0.01% 1128
2022
Q2
$652K Buy
13,200
+3,953
+43% +$196K 0.01% 1263
2022
Q1
$487K Buy
+9,247
New +$517K 0.01% 1554
2021
Q2
Sell
-14,764
Closed -$1.31M 2571
2021
Q1
$1.31M Buy
+14,764
New +$1.46M 0.02% 768
2020
Q2
Sell
-3,893
Closed -$217K 1897
2020
Q1
$217K Buy
+3,893
New +$296K 0.01% 761
2019
Q3
Sell
-5,015
Closed -$314K 1484
2019
Q2
$314K Buy
+5,015
New +$279K 0.01% 671

Other funds holding ITRI

Michael Gelband's ITRI Position: Q2 2026 in Review

Michael Gelband sold out of Itron (ITRI) in Q2 2026, closing a stake of 6,407 shares — an estimated $574K sold.

Michael Gelband first reported a position in ITRI in Q2 2019 and held it in 16 quarters. The position peaked at $4.24M in Q3 2024. 409 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Michael Gelband reported no remaining Itron position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 6,407 Itron shares in Q2 2026, an estimated $574K.
  • Michael Gelband first reported a position in Itron in Q2 2019 and held it in 16 quarters.
  • Michael Gelband's Itron position peaked at $4.24M in Q3 2024.
  • 409 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.